COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks for extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

Implementation of an electronic health record order set increases compliance with the recommended duration of prescribed antibiotics for children with acute otitis media.

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

Older adults who received the bivalent BNT162b2 vaccine were less likely to develop long COVID symptoms follow acute ...

Early antiviral therapy with obeldesivir was safe and well tolerated in patients at high risk for severe COVID-19 and ...

In patients with uncomplicated UTI, the presence of positive vs negative ESBL uropathogens differed by symptom severity, race, and age plus recurrent UTI history.

There were no safety concerns identified among older adults following revaccination with the investigational respiratory syncytial virus vaccine mRNA-1345, and immune responses elicited by ...

High rates of virologic suppression were observed among Black patients who received long-term ART with BIC/FTC/TAF for HIV management.

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.